These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 3808121)
1. Antitumor activity of four polymer bound trans-1,2-diaminocyclohexaneplatinum(II)-4-carboxyphtalate complexes tested in different model systems. Balázová E; Hrubisko M; Drobník J; Ujházy V Neoplasma; 1986; 33(6):665-70. PubMed ID: 3808121 [TBL] [Abstract][Full Text] [Related]
2. Antitumor activity and cross-resistance studies with Pt-ascorbato complexes. Hrubisko M; Balázová E; Kiss F; Kovácová J; Ujházy V Neoplasma; 1989; 36(6):651-7. PubMed ID: 2615869 [TBL] [Abstract][Full Text] [Related]
3. Drug resistance induction and cross-resistance studies with Pt-complexes. Hrubisko M; Balázová E; Ujházy V Neoplasma; 1984; 31(6):649-53. PubMed ID: 6542968 [TBL] [Abstract][Full Text] [Related]
4. Comparison of the effectivity of two diaminocyclohexane Pt-complexes. Balázová E; Hrubisko M; Ujházy V Neoplasma; 1985; 32(5):537-42. PubMed ID: 4069288 [TBL] [Abstract][Full Text] [Related]
5. In vivo and in vitro effectivity of some platinum complexes. Balázová E; Hrubisko M; Ujházy V Neoplasma; 1984; 31(6):641-7. PubMed ID: 6395026 [TBL] [Abstract][Full Text] [Related]
6. Chemical and biological studies on a series of novel (trans-(1R,2R)-, trans-(1S,2S)-, and cis-1,2-diaminocyclohexane)platinum(IV) carboxylate complexes. Khokhar AR; al-Baker S; Shamsuddin S; Siddik ZH J Med Chem; 1997 Jan; 40(1):112-6. PubMed ID: 9016335 [TBL] [Abstract][Full Text] [Related]
7. Axial ligands and alicyclic ring size modulate the activity and biochemical pharmacology of ammine/cycloalkylamine-platinum(IV) complexes in tumor cells resistant to cis-diamminedichloroplatinum(II) or trans-1R,2R-1S,2S-diaminocyclohexanetetrachloroplatinum(IV). Yoshida M; Khokhar AR; Siddik ZH Cancer Res; 1994 Sep; 54(17):4691-7. PubMed ID: 8062266 [TBL] [Abstract][Full Text] [Related]
8. Synthesis, physical properties, and antitumor activity of tetraplatin and related tetrachloroplatinum(IV) stereoisomers of 1,2-diaminocyclohexane. Anderson WK; Quagliato DA; Haugwitz RD; Narayanan VL; Wolpert-DeFilippes MK Cancer Treat Rep; 1986 Aug; 70(8):997-1002. PubMed ID: 3731155 [TBL] [Abstract][Full Text] [Related]
9. Modulatory effect of axial and equatorial ligands on antitumor activities of trans-1R,2R-diaminocyclohexane platinum(IV) complexes. Siddik ZH; al-Baker S; Thai G; Khokhar AR Anticancer Drug Des; 1994 Apr; 9(2):139-51. PubMed ID: 8166929 [TBL] [Abstract][Full Text] [Related]
10. Tetravalent platinum complexes with ammine/amine carrier ligand configuration: circumvention of platinum resistance in vivo. Siddik ZH; Thai G; Yoshida M; Zhang YP; Khokhar AR Anticancer Drug Des; 1994 Dec; 9(6):495-509. PubMed ID: 7880375 [TBL] [Abstract][Full Text] [Related]
11. Novel trans platinum complexes: comparative in vitro and in vivo activity against platinum-sensitive and resistant murine tumours. Goddard PM; Orr RM; Valenti MR; Barnard CF; Murrer BA; Kelland LR; Harrap KR Anticancer Res; 1996; 16(1):33-8. PubMed ID: 8615631 [TBL] [Abstract][Full Text] [Related]
12. Modulation of cytotoxicity and cellular pharmacology of 1,2-diaminocyclohexane platinum (IV) complexes mediated by axial and equatorial ligands. Kido Y; Khokhar AR; al-Baker S; Siddik ZH Cancer Res; 1993 Oct; 53(19):4567-72. PubMed ID: 8402629 [TBL] [Abstract][Full Text] [Related]
13. Treatment and prophylaxis of experimental liver metastases of M5076 reticulosarcoma with cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexaneplatinum (II) encapsulated in multilamellar vesicles. Perez-Soler R; Khokhar AR; Lopez-Berestein G Cancer Res; 1987 Dec; 47(24 Pt 1):6462-6. PubMed ID: 3315188 [TBL] [Abstract][Full Text] [Related]
14. [Testing antineoplastic activity of new platinum(II) and palladium(II) complex compounds]. Malinowska K; Modranka R; Kubiak K; Mrowicka M; Klimczak A; Kedziora J; Rutkowski M Pol Merkur Lekarski; 2009 Jan; 26(151):57-61. PubMed ID: 19391509 [TBL] [Abstract][Full Text] [Related]
15. Increased cytotoxicity and reversal of resistance to cis-diamminedichloro-platinum(II) with entrapment of cis-Bis-neodecanoato-trans-R,R-1,2-diaminocyclohexaneplatinum (II) in multilamellar lipid vesicles. Perez-Soler R; Yang LY; Drewinko B; Lauterzstain J; Khokhar AR Cancer Res; 1988 Aug; 48(16):4509-12. PubMed ID: 3396003 [TBL] [Abstract][Full Text] [Related]
16. Synthesis, cytotoxicity and antitumor activity of platinum(II) complexes of cyclopentanecarboxylic acid hydrazide. Kushev D; Gorneva G; Taxirov S; Spassovska N; Grancharov K Biol Chem; 1999 Nov; 380(11):1287-94. PubMed ID: 10614821 [TBL] [Abstract][Full Text] [Related]
17. Role of carrier ligand in platinum resistance of human carcinoma cell lines. Schmidt W; Chaney SG Cancer Res; 1993 Feb; 53(4):799-805. PubMed ID: 8428361 [TBL] [Abstract][Full Text] [Related]
18. Preparation of antitumor oxaliplatin/cisplatin docking dinuclear platinum complex. Noji M; Kizu R; Takeda Y; Akiyama N; Yoshizaki I; Eriguchi M; Kidani Y Biomed Pharmacother; 2005 Jun; 59(5):224-9. PubMed ID: 15919175 [TBL] [Abstract][Full Text] [Related]
19. Murine leukemia L1210 cell lines with different patterns of resistance to platinum coordination complexes. Eastman A; Illenye S Cancer Treat Rep; 1984 Sep; 68(9):1189-90. PubMed ID: 6541096 [TBL] [Abstract][Full Text] [Related]
20. Ascorbato(1,2-diaminocyclohexane):platinum(II) complexes, a new series of water-soluble antitumor drugs. Hacker MP; Khokhar AR; Brown DB; McCormack JJ; Krakoff IH Cancer Res; 1985 Oct; 45(10):4748-53. PubMed ID: 4040806 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]